Half-time seminars Half-time review: Henrik Alfredéen

16-09-2026 1:00 pm Add to iCal
Karolinska University Hospital, Solna J3:14 Kerstin Hagenfeldt, BioClinicum, Solnavägen 30

Development of novel targeted alpha therapy (TAT) for high-risk neuroblastoma

Half-time board

  • Associate professor Alex Poot, UMC Utrecht
  • PhD Anzhelika Vorobyeva, Uppsala University
  • PhD Diana Spiegelberg, Uppsala University

Principal supervisor

  • Docent Thuy Tran, Karolinska Institutet, Department of Oncology-Pathology

Co-supervisors

  • PhD Kasper Karlsson, Karolinska Institutet, Department of Oncology-Pathology
  • Docent Jakob Stenman, Karolinska Institutet, Department of Women's and Children's Health
  • PhD Erik Samén, Karolinska Institutet, Department of Oncology-Pathology

Welcome!